Sign in

CIK 0001124105

  • Accelerated filer
  • Smaller reporting company

GYRE THERAPEUTICS, INC.

Sign in to watch
Ticker
GYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562020050
Phone
+1 858-284-0115
Business address
12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
Former names
CATALYST BIOSCIENCES, INC., TARGACEPT INC
  1. 4 Exercise or conversion President & CEO acquired 5,729 shares (option exercise)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Grant or award Director acquired 1,544 shares (grant or award)
  6. 4 Grant or award Director acquired 2,732 shares (grant or award)
  7. 4 Grant or award Director acquired 811 shares (grant or award)
  8. 4 Grant or award Director acquired 1,703 shares (grant or award)
  9. 4 Exercise or conversion Chief Medical Officer acquired 149 shares (option exercise)
  10. 4 Open-market sale Chief Medical Officer sold 173 shares at $11.00 ($1,903)
  11. 4 Returned to the company Director returned 190 shares (to the company)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 3/A Insider 3/A
  16. 3 Insider Initial Statement of Ownership
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 14 of 37 · 739 filings